Shantaram S. Joshi
Affiliations: | Genetics, Cell Biology, and Anatomy | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Cell Biology, Genetics, Molecular Biology, OncologyGoogle:
"Shantaram Joshi"Children
Sign in to add traineeAvadhut D. Joshi | grad student | 2006 | University of Nebraska Medical Center |
Corey M. Munger | grad student | 2007 | University of Nebraska Medical Center |
Amit K. Mittal | grad student | 2010 | University of Nebraska Medical Center |
Tara M. Nordgren | grad student | 2011 | University of Nebraska Medical Center |
Christine E. Cutucache | grad student | 2012 | University of Nebraska Medical Center |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Chaturvedi NK, Kling MJ, Griggs CN, et al. (2020) A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma. Molecular Cancer Therapeutics |
Song H, Bhakat R, Kling MJ, et al. (2019) Targeting cyclin-dependent kinase 9 sensitizes medulloblastoma cells to chemotherapy. Biochemical and Biophysical Research Communications |
Chaturvedi NK, Hatch ND, Sutton GL, et al. (2018) A novel approach to eliminate therapy-resistant mantle cell lymphoma: synergistic effects of Vorinostat with Palbociclib. Leukemia & Lymphoma. 1-10 |
Chaturvedi NK, Kling MJ, Coulter DW, et al. (2018) Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy. Oncotarget. 9: 16619-16633 |
Ray S, Coulter DW, Gray SD, et al. (2017) Suppression of STAT3 NH2 -Terminal Domain Chemosensitizes Medulloblastoma Cells by Activation of Protein Inhibitor of Activated STAT3 via de-repression by MicroRNA-21. Molecular Carcinogenesis |
Chaturvedi NK, Hatch ND, Sutton GL, et al. (2017) Abstract 4051: Combination efficacy of HDAC inhibitor vorinostat and CDK-4/6 dual inhibitor palbociclib against therapy-resistant mantle cell lymphoma Cancer Research. 77: 4051-4051 |
Chaturvedi NK, Coulter DW, McGuire TR, et al. (2017) Abstract 161: Medulloblastoma therapy targeting Hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy Cancer Research. 77: 161-161 |
Ray S, Coulter DW, Gray SD, et al. (2017) Abstract 1064: STAT3 NH2-terminal domain inhibition sensitizes medulloblastoma cells to chemotherapy Cancer Research. 77: 1064-1064 |
Coulter DW, McGuire TR, Sharp JG, et al. (2016) Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513. Bmc Cancer. 16: 867 |
Haney SL, Upchurch GM, Opavska J, et al. (2016) Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice. Scientific Reports. 6: 34222 |